Furthermore, although we confirmed the finding that ruscogenin inhibits pyroptosis and thereby alleviates colitis through the TLR4/NF-κB pathway, transgenic mouse experiments are necessary to verify this pathway before using ruscogenin in IBD patients. Here, TLR4 is linked to colitis.